There are three types of neurofibromatosis: neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2) and schwannomatosis.
Is there a neurofibromatosis Type 3?
Neurofibromatosis (NF) type 3 (NF3), also known as schwannomatosis, is the least frequent form of the rare genetic disorder neurofibromatosis.
Is neurofibromatosis type 1 rare?
NF1 is a rare disorder that affects males and females in equal numbers. NF1 affects all races and ethnic groups equally and is estimated to occur in 1 in 2,500 to 3,000 births.
What are the different types of neurofibromatosis?
Neurofibromatosis is a rare genetic disorder that causes typically benign tumors of the nerves and growths in other parts of the body. Some people with this disorder have barely noticeable neurological problems, while others are affected profoundly. There are two major types: neurofibromatosis type I (NF1) and neurofibromatosis type II (NF2).
Are there any new drugs for neurofibromatosis type 1?
In April 2020 the U.S. Food and Drug Administration approved selumetinib (Koselugo) as a treament for children ages 2 years and older wth neurofibromatosis type 1. The drug helps to stop tumor cells from growing.
What are the side effects of neurofibromatosis ( NF2 )?
Complications of NF2 include: Partial or total deafness Facial nerve damage Vision problems Small benign skin tumors (skin schwannomas) Weakness or numbness in the extremities Multiple benign brain tumors or spinal tumors (meningiomas) requiring frequent surgeries
Which is the most common type of tumor in NF1?
Most tumors associated with NF1 are benign (non-cancerous) skin tumors, which grow on nerves throughout the body. Neurofibromas (NFs) are the most common type of tumor in people with NF1. The two major types of neurofibromas are: Dermal (sub-cutaneous) neurofibromas are small, nodule-like tumors that grow on or just under the surface of the skin.